AFL · Aflac Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.35B | - | $4.74B | $4.16B | $3.40B | - | $2.95B | $5.14B | $5.44B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $771.00M | - | $781.00M | $804.00M | $802.00M | - | $747.00M | $694.00M | $739.00M | - |
| Total Operating Expenses | $1.29B | - | $1.31B | $1.33B | $1.31B | - | $1.26B | $1.20B | $1.26B | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | $1.23B | - | $1.99B | $822.00M | $145.00M | - | $92.00M | $2.02B | $2.17B | - |
| Interest Expense | $59.00M | - | $56.00M | $51.00M | $49.00M | - | $49.00M | $50.00M | $47.00M | - |
| Income Tax | $206.00M | - | $355.00M | $223.00M | $116.00M | - | $185.00M | $264.00M | $291.00M | - |
| Net Income | $1.02B | - | $1.64B | $599.00M | $29.00M | - | ($93.00M) | $1.75B | $1.88B | - |
| EPS - Basic | $1.99 | - | $3.09 | $1.12 | $0.05 | - | ($0.17) | $3.11 | $3.27 | - |
| EPS - Diluted | $1.98 | - | $3.08 | $1.11 | $0.05 | - | ($0.17) | $3.10 | $3.25 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.65B | $6.25B | $6.77B | $6.96B | $5.23B | $6.23B | $5.61B | $6.06B | $5.10B | $4.31B |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $116.28B | $116.47B | $122.31B | $124.74B | $120.26B | $117.57B | $128.44B | $120.17B | $124.74B | $126.72B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $86.32B | $86.98B | $93.62B | $97.54B | $93.92B | $91.47B | $103.61B | $94.12B | $101.20B | $104.74B |
| Stockholders' Equity | $29.96B | $29.49B | $28.69B | $27.20B | $26.34B | $26.10B | $24.83B | $26.05B | $23.54B | $21.98B |
| Retained Earnings | $55.70B | $54.68B | $53.92B | $52.59B | $52.31B | $52.28B | $50.97B | $51.34B | $49.87B | $47.99B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $968.00M | - | - | - | $589.00M | - | - | - | $849.00M | - |
| Investing Cash Flow | $244.00M | - | - | - | ($359.00M) | - | - | - | $227.00M | - |
| Financing Cash Flow | ($1.76B) | - | - | - | ($1.26B) | - | - | - | ($256.00M) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 28.2% | - | 42.1% | 19.8% | 4.3% | - | 3.1% | 39.3% | 39.9% | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | 23.4% | - | 34.6% | 14.4% | 0.9% | - | -3.2% | 34.2% | 34.6% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 17.7% | - | 16.5% | 19.3% | 23.6% | - | 25.3% | 13.5% | 13.6% | - |
| Effective tax rate | 16.8% | - | 17.8% | 27.1% | 80.0% | - | 201.1% | 13.1% | 13.4% | - |
| Return on assets | 0.9% | - | 1.3% | 0.5% | 0.0% | - | -0.1% | 1.5% | 1.5% | - |
| Return on equity | 3.4% | - | 5.7% | 2.2% | 0.1% | - | -0.4% | 6.7% | 8.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 20.8x | - | 35.6x | 16.1x | 3.0x | - | 1.9x | 40.4x | 46.2x | - |
| Equity multiplier | 3.88 | 3.95 | 4.26 | 4.59 | 4.57 | 4.50 | 5.17 | 4.61 | 5.30 | 5.76 |
| Liabilities / Assets | 0.74 | 0.75 | 0.77 | 0.78 | 0.78 | 0.78 | 0.81 | 0.78 | 0.81 | 0.83 |
| Efficiency | ||||||||||
| Asset turnover | 0.04 | - | 0.04 | 0.03 | 0.03 | - | 0.02 | 0.04 | 0.04 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 55.4x | - | 36.3x | 95.0x | 2223.8x | - | - | 28.8x | 26.4x | - |
| P / B | 1.9x | - | 2.1x | 2.1x | 2.3x | - | 2.5x | 1.9x | 2.1x | - |
| P / S | 13.0x | - | 12.5x | 13.6x | 17.9x | - | 21.2x | 9.9x | 9.1x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 27.9% | - | 60.7% | -19.0% | -37.5% | - | -40.4% | -0.7% | 13.3% | - |
| Revenue CAGR (3y) | -3.3% | - | -0.6% | -8.3% | -13.6% | - | -17.4% | -2.6% | -2.5% | - |
| Revenue CAGR (5y) | -5.8% | - | -3.5% | -5.1% | -8.0% | - | -11.8% | -1.4% | -0.8% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 744.8% | - | 2067.4% | -59.3% | -93.3% | - | -92.9% | 77.3% | 91.5% | - |
| Net income growth (YoY) | 3413.8% | - | - | -65.9% | -98.5% | - | - | 7.4% | 58.2% | - |
| EPS growth (YoY) | 3860.0% | - | - | -64.2% | -98.5% | - | - | 14.4% | 67.5% | - |
| EPS CAGR (3y) | 0.7% | - | 6.8% | -19.9% | -68.4% | - | - | 24.2% | 20.2% | - |
| EPS CAGR (5y) | 1.1% | - | -2.2% | -0.2% | -42.3% | - | - | 23.3% | 21.4% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 13.8% | 13.0% | 15.5% | 4.4% | 11.9% | 18.7% | 9.5% | 27.4% | 19.0% | -1.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$17.54B totalAflac Japan$9.36B · 53.4%
Aflac US$6.90B · 39.4%
Corporate And Other$1.28B · 7.3%
Peer comparison
Same SIC group: Accident & Health Insurance
Comparing AFLAC INC against the 4 most active filers in the same SIC group.
Dividends
$2.38/share trailing 12 months · +10.2% YoY
| Ex-date | Per share |
|---|---|
| May 20, 2026 | $0.6100 |
| Feb 18, 2026 | $0.6100 |
| Nov 19, 2025 | $0.5800 |
| Aug 20, 2025 | $0.5800 |
| May 21, 2025 | $0.5800 |
| Feb 19, 2025 | $0.5800 |
| Nov 20, 2024 | $0.5000 |
| Aug 21, 2024 | $0.5000 |
| May 21, 2024 | $0.5000 |
| Feb 20, 2024 | $0.5000 |
| Nov 14, 2023 | $0.4200 |
| Aug 22, 2023 | $0.4200 |
| May 16, 2023 | $0.4200 |
| Feb 14, 2023 | $0.4200 |
| Nov 15, 2022 | $0.4000 |
| Aug 23, 2022 | $0.4000 |
| May 17, 2022 | $0.4000 |
| Feb 15, 2022 | $0.4000 |
| Nov 16, 2021 | $0.3300 |
| Aug 17, 2021 | $0.3300 |
| May 18, 2021 | $0.3300 |
| Feb 16, 2021 | $0.3300 |
| Nov 17, 2020 | $0.2800 |
| Aug 18, 2020 | $0.2800 |